EUVIMEDDescubrir EUVIMED
Crossref

Evaluation of Epidermal Growth Factor Receptor and Its Inducible Feedback Inhibitor Leucine Rich Repeats and Immunoglobulin Like Domains 1 as Prognostic Marker in Oral Cancer

Deepika Verma iD, S S Chauhan, Joginder Kumar, Mohit Arora, Qulsum Akhtar, Lokesh Kadian, Prerna Jain, Vivek Nayyar, Ajoy Roychaudhury, Deepika Mishra iD, Alok Thakar, Riyaz A Mir

Molecular Carcinogenesis · 2026-05 · 65 (5) · 630-641

DOI: 10.1002/mc.70103 ↗

At a glance

Journal article in Molecular Carcinogenesis, published online on 2026-03-01. Written by Deepika Verma and 11 co-authors. Institution: Department of Biochemistry, All India Institute of Medical Sciences (AIIMS), New Delhi, India. Major MEDLINE topics: Mouth Neoplasms, Biomarkers, Tumor, ErbB Receptors, Carcinoma, Squamous Cell. 37 references.

ResumenSubjectsDatos bibliográficosCiteRelated studies

Abstract (original language)

Oral squamous cell carcinoma (OSCC) is a life‐threatening disease that ranks sixth amongst the most common human cancers worldwide. In most cases, OSCC development is preceded by oral premalignant disorders (OPMDs). There is an urgent need for more biomarker studies that will aid in early detection, diagnosis, and treatment of OPMD to prevent their transformation to OSCC. Leucine rich repeats and immunoglobulin like domains 1 (LRIG1) are known to negatively regulate EGFR expression. Little is known about the significance of LRIG1 in oral cancer pathogenesis. In a retrospective study, immunohistochemical analysis of EGFR and LRIG1 was carried out in 212 archival oral tissues (100 OSCC, 87 OPMD, and 25 normal), correlated with clinicopathological parameters and disease outcome over 62 months for OSCC patients. Further, gene expression for EGFR and LRIG1 was also evaluated in 160 tissue samples. Significant increase in EGFR in OSCC tissue was observed compared to controls, while LRIG1 levels were found to be downregulated in OSCC and OPMD cases compared to normal tissues ( p < 0.05). Kaplan–Meier analysis of patients stratified to high and low LRIG1 expression showed significantly different overall survival ( p < 0.05, median survival 1397 and 561 days, respectively). A unique translational impact of our study is that it provides clinical evidence for the potential of LRIG1 downregulation as predictor of poor prognosis in OSCC. These preliminary findings support further research to validate LRIG1 based prognostic tools for oral cancers.

Subjects

MeSH terms (MEDLINE)

Mouth NeoplasmsBiomarkers, TumorErbB ReceptorsCarcinoma, Squamous CellMembrane GlycoproteinsHumansFemalePrognosisMaleMiddle AgedRetrospective StudiesAgedAdultGene Expression Regulation, Neoplastic

Author keywords

EGFRLRIG1biomarkeroral canceroral dysplasia

Substances

LRIG1 protein, humanBiomarkers, TumorErbB ReceptorsMembrane GlycoproteinsEGFR protein, human

Authors and institutions

  • Department of Biochemistry, All India Institute of Medical Sciences (AIIMS), New Delhi, India.
  • Department of Statistics, Central University of Haryana, Mahendergarh, India.
  • Department of Biochemistry, Sri Pratap College, Srinagar, India.
  • Department of Dermatology, School of Medicine, Indiana University, Indianapolis, Indiana, USA.
  • Department of Oral Pathology and Microbiology, CDER, All India Institute of Medical Sciences (AIIMS), New Delhi, India.
  • Department of Oral and Maxillofacial Surgery, CDER, All India Institute of Medical Sciences (AIIMS), New Delhi.

ORCID profiles: Deepika Verma, Deepika Mishra

Cite

APA

Verma, D., Chauhan, S. S., Kumar, J., Arora, M., Akhtar, Q., Kadian, L., Jain, P., Nayyar, V., Roychaudhury, A., Mishra, D., Thakar, A., & Mir, R. A. (2026). Evaluation of Epidermal Growth Factor Receptor and Its Inducible Feedback Inhibitor Leucine Rich Repeats and Immunoglobulin Like Domains 1 as Prognostic Marker in Oral Cancer. Molecular Carcinogenesis, 65(5), 630-641. https://doi.org/10.1002/mc.70103

Vancouver

Verma D, Chauhan SS, Kumar J, Arora M, Akhtar Q, Kadian L, et al. Evaluation of Epidermal Growth Factor Receptor and Its Inducible Feedback Inhibitor Leucine Rich Repeats and Immunoglobulin Like Domains 1 as Prognostic Marker in Oral Cancer. Molecular Carcinogenesis. 2026;65(5):630-641. doi:10.1002/mc.70103

BibTeX
@article{Verma2026,
  author = {Verma, Deepika and Chauhan, S S and Kumar, Joginder and Arora, Mohit and Akhtar, Qulsum and Kadian, Lokesh and Jain, Prerna and Nayyar, Vivek and Roychaudhury, Ajoy and Mishra, Deepika and Thakar, Alok and Mir, Riyaz A},
  title = {Evaluation of Epidermal Growth Factor Receptor and Its Inducible Feedback Inhibitor Leucine Rich Repeats and Immunoglobulin Like Domains 1 as Prognostic Marker in Oral Cancer},
  journal = {Molecular Carcinogenesis},
  year = {2026},
  volume = {65},
  number = {5},
  pages = {630--641},
  doi = {10.1002/mc.70103}
}
Start for free →